CannLabs, Inc. (CANL) 是一家上市公司 属于 医疗保健 板块，经营于 制药 - 专科与仿制药 行业. 公司总部位于 Denver, CO, 美国. 现任CEO为 Mark C. Mirken.
CANL 拥有 IPO日期为 2014-06-13, 37 名全职员工, 在 Other OTC, 市值为 $93.32K.
CannLabs, Inc. provides cannabis testing laboratory services in the United States. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing. The company also offers data/analytics and consulting, as well as education services. CannLabs, Inc. is based in Denver, Colorado.
